GEN İlaç
Founded in 1998, GEN is one of the fastest-growing pharmaceutical companies in Türkiye. The company partners with leading global pharmaceutical companies to bring innovative therapies and solutions for rare diseases to patients and healthcare systems.
Operating in full compliance with ethical and scientific principles, GEN is committed to setting high benchmarks for quality, safety, and value across the pharmaceutics. With a GMP-certified manufacturing facility and R&D center located in Ankara, GEN develops and produces medicines that address unmet medical needs both in Türkiye and internationally.
In addition to its headquarters and operations in Türkiye, GEN has an expanding international presence with offices in Germany, Russia, Kazakhstan, Uzbekistan, and Azerbaijan.
Eczacıbaşı Momentum
Founded in 2019 as the corporate venture capital arm of Eczacıbaşı Holding, Eczacıbaşı Momentum focuses on investing in high-impact start-ups and transformative technologies. The fund targets companies operating in the fields of wellbeing, consumer products, and home living that are shaping the new normal of modern life and demonstrate strong international growth potential.
Eczacıbaşı Momentum places particular emphasis on innovative technologies and scalable business models. Beyond financial investment, portfolio companies benefit from access to extensive industry experience, operational know-how and global business network of the Eczacıbaşı Group.
İstanbul Portföy Yönetimi (One Life Ventures)
Founded in 2007, Istanbul Portföy Yönetimi Asset Management is Türkiye’s largest domestic and independent portfolio management company, managing assets totalling approximately 16.7 billion TL as of November 2021. in August 2021, the firm expanded its venture capital activities into the healthcare industry through the launch of One Life Ventures Venture Capital Investment Fund, adding it to its portfolio of 10 venture capital investment funds. One Life Ventures focuses on investments in innovative healthcare and life sciences companies with strong growth potential.
ACT Venture Partners
Founded in July 2015 in the Netherlands, ACT Venture Partners is a venture capital firm focused on early-stage technology and innovation investments in Türkiye. The fund’s investor base includes the European Investment Fund (EIF) as the anchor investor, alongside a group of private and institutional investors.
